OTTAWA, Aug 5, 2016 /CNW/ -
Health Canada is advisingCanadians that Pharmascience Inc. has initiated a voluntary recall of one lot of pms-Atenolol 100 mg, used to treat cardiovascular conditions such as hypertension (high blood pressure), due to a labelling error. The lot contains foil blister packs incorrectly
The labelling error could result in a patient taking a double dose of the product. This could result in excessively low blood pressure and decreased heart rate, particularly in elderly patients and patients with impaired kidney function, which may cause dizziness, fainting and falling. Other symptoms could include drowsiness, tiredness, nausea and diarrhea.
pms-Atenolol 100 mg (Lot: 495259) expiry May 31, 2017
Who is affected:
Canadians who have used or purchased this product.
What consumers should do:
What Health Canada is doing:
Health Canada is monitoring the recall. Should new information become available, Health Canada will take appropriate action and inform Canadians.
How to report side effects to health products to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls usingsocial media tools.
Également disponible en français
SOURCE Health Canada
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All